合成路线1
该中间体在本合成路线中的序号:
(I) AHR-53338 is synthesized in an overall yield of 62% from ethyl isonipecotate (I):
Ethyl isonipecotate (I) is protected with benzyl bromide (II) to give (III), which is then treated with 2.5 moles of 4-fluorophenylmagnesium bromide to give the tertiary alcohol (IV). The benzyl group is removed by catalytic hydrogenolysis to give the secondary piperidine (V). The reaction of 1-bromo-3-chloropropane (VI) with acetovanillone (VII) gives 1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone (VIII) in excellent yield. A mixture of (V) and (VIII) in 1-butanol and triethylamine heated at reflux yields AHR-53338 isolated as the mandelic acid salt.
【1】
Yanni, J.M.; Walsh, D.A.; Franzyshen, S.K.; The synthesis and antiallergy activity of 1-[4-[3-. 193rd ACS Natl Meet 1987, Abst MEDI 85.
|
【2】
Yanni, J.M.; Walsh, D.A.; AHR-5333B. Drugs Fut 1988, 13, 7, 605.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
13643 |
4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide |
352-13-6 |
C6H4BrFMg |
详情 | 详情
|
(B) |
28161 |
2-hydroxy-2-phenylacetic acid
|
611-72-3 |
C8H8O3 |
详情 | 详情
|
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(III) |
22600 |
ethyl 1-benzyl-4-piperidinecarboxylate; N-Benzyl-4-carbethoxy piperidine
|
24228-40-8 |
C15H21NO2 |
详情 | 详情
|
(IV) |
22601 |
(1-benzyl-4-piperidinyl)[bis(4-fluorophenyl)]methanol
|
|
C25H25F2NO |
详情 |
详情
|
(V) |
22602 |
bis(4-fluorophenyl)(4-piperidinyl)methanol
|
60284-98-2 |
C18H19F2NO |
详情 | 详情
|
(VI) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(VII) |
22604 |
1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone |
498-02-2 |
C9H10O3 |
详情 | 详情
|
(VIII) |
22605 |
4-(3-Chloropropoxy)-3-Methoxyacetophenone;3-(4-Acetyl-2-methoxyphenoxy)propyl chloride;1-(4-(3-chloropropoxy)-3-methoxyphenyl)ethanone;1-[4-(3-chloropropoxy)-3-methoxyphenyl]-1-ethanone |
58113-30-7 |
C12H15ClO3 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(XVIII) 3) Racemic MDL-100907 (VII) can also be obtained as follows: The reaction of piperidine-4-carboxylic acid ethyl ester (XVIII) with the previously mentioned bromide (II) by means of K2CO3 as before gives 1-[2-(4-fluorophenyl)ethyl]piperidine-4-carboxylic acid ethyl ester (XIX), which is treated with N,O-dimethylhydroxylamine (XIII) to afford carboxamide (XX). The condensation of (XX) with veratrole (VI) by means of BuLi as before yields the ketonic precursor (XVII), which is finally reduced as before.
4) [11C]-Radiolabeled MDL-100907 can be obtained as follows: Racemic MDL-100907 (VII) is treated with L-Selectride in THF, yielding racemic 1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]-1-(3-hydroxy-2-methoxy-phenyl)methanol (rac-XXI), which is submitted to semi-preparative HPLC separation over Chiracel OD, affording pure (R-XXI). Finally, this compound is methylated with [11C]-methyl iodide and KOH in HMPA. If this methylation is performed with nonlabeled methyl iodide, MDL-100907 is obtained.
5) The radiolabeling of phenol (R-XXI) can also be performed with better yields using [11C]-methyl trifluoromethanesulfonate (XXII) as methylating agent. Triflate (XXII) is obtained by reaction of silver triflate with [11C]-methyl iodide.
【1】
Mathis, C.A.; Mahmood, K.; Price, J.C.; Huang, Y.; Gerdes, J.M.; Simpson, N.R.; Synthesis and preliminary in vivo evaluation of [11C]MDL 100907: A potent and selective radioligand for the 5-HT2A receptor system. Med Chem Res 1996, 6, 1, 1-10.
|
【2】
Castaner, J.; Sorbera, L.A.; Silvestre, J.S.; MDL-100907. Drugs Fut 1998, 23, 9, 955.
|
【3】
Hiyama, T.; Minami, T.; Hanamoto, T.; Reddy, G.B. (Sagami Chemical Research Center); Optically active esters of 7-substd. 3,5-difunctionalized 6-heptenoic acids. EP 0475627 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
17394 |
1-(2-bromoethyl)-4-fluorobenzene
|
|
C8H8BrF |
详情 |
详情
|
(VI) |
17398 |
2-methoxyphenyl methyl ether; Veratrole; 1,2-dimethoxybenzene
|
91-16-7 |
C8H10O2 |
详情 | 详情
|
(VII) |
17399 |
(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanol
|
|
C22H28FNO3 |
详情 |
详情
|
(XIII) |
13361 |
(Methoxyamino)methane; N,O-Dimethylhydroxylamine
|
1117-97-1 |
C2H7NO |
详情 | 详情
|
(XVII) |
17409 |
(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanone
|
|
C22H26FNO3 |
详情 |
详情
|
(XVIII) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(XIX) |
17411 |
ethyl 1-(4-fluorophenethyl)-4-piperidinecarboxylate
|
|
C16H22FNO2 |
详情 |
详情
|
(XX) |
17412 |
1-(4-fluorophenethyl)-N-methoxy-N-methyl-4-piperidinecarboxamide
|
|
C16H23FN2O2 |
详情 |
详情
|
(XXI) |
17413 |
3-[(R)-[1-(4-fluorophenethyl)-4-piperidinyl](hydroxy)methyl]-2-methoxyphenol
|
|
C21H26FNO3 |
详情 |
详情
|
(XXII) |
17414 |
methyl trifluoromethane sulfonate; methyl trifluoromethanesulfonate
|
333-27-7 |
C2H3F3O3S |
详情 | 详情
|
(XXII) |
45233 |
methyl trifluoromethanesulfonate
|
|
C2H3F3O3S |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) The synthesis of MDL-100907 [11C]-labeled at the 2'-methoxy group has been reported: Condensation of 2-(4-fluorophenyl)ethyl bromide (I) with piperidine-4-carboxylic acid ethyl ester (II) by means of K2CO3 in DMF gives 1-[2-(4-fluorophenyl)ethyl]piperidine-4-carboxylic acid ethyl ester (III), which is treated with N,O-dimethylhydroxylamine and ethylmagnesium bromide in THF to yield compound (IV). Condensation of (IV) with veratrole (V) by means of BuLi in THF affords the 4-benzoylpiperidine derivative (VI), which is reduced with NaBH4 in methanol to give the racemic carbinol (VII). Optical resolution of (VII) by esterification with (S)-2-methoxy-2-phenylacetic acid (VIII) by means of DCC and DMAP in chloroform followed by column chromatography yields the diastereomer (IX), which is hydrolyzed with K2CO3 in methanol to afford MDL-100907 (X). Selective demethylation of (X) with L-selectride in THF gives the 2'-hydroxy derivative (XI), which is finally remethylated with [11C]-methyl iodide and K2CO3 in methanol.
【1】
Mathis, C.A.; Huang, Y.Y.; Mahmood, K.; An efficient synthesis of the precursors of [11C]MDL 100907 labeled in two specific positions. J Label Compd Radiopharm 1999, 42, 10, 949.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17394 |
1-(2-bromoethyl)-4-fluorobenzene
|
|
C8H8BrF |
详情 |
详情
|
(II) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(III) |
17411 |
ethyl 1-(4-fluorophenethyl)-4-piperidinecarboxylate
|
|
C16H22FNO2 |
详情 |
详情
|
(IV) |
17412 |
1-(4-fluorophenethyl)-N-methoxy-N-methyl-4-piperidinecarboxamide
|
|
C16H23FN2O2 |
详情 |
详情
|
(V) |
40496 |
tert-butyl(2-methoxyphenoxy)diphenylsilane; tert-butyl(diphenyl)silyl 2-methoxyphenyl ether
|
|
C23H26O2Si |
详情 |
详情
|
(VI) |
17409 |
(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanone
|
|
C22H26FNO3 |
详情 |
详情
|
(VII) |
17399 |
(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanol
|
|
C22H28FNO3 |
详情 |
详情
|
(VIII) |
17400 |
(2S)-2-methoxy-2-phenylethanoic acid
|
|
C9H10O3 |
详情 |
详情
|
(IX) |
17401 |
(R)-(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methyl (2S)-2-methoxy-2-phenylethanoate
|
|
C31H36FNO5 |
详情 |
详情
|
(X) |
40494 |
(R)-(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanol
|
|
C22H28FNO3 |
详情 |
详情
|
(XI) |
40495 |
2-[(R)-[1-(4-fluorophenethyl)-4-piperidinyl](hydroxy)methyl]-6-methoxyphenol
|
|
C21H26FNO3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) The synthesis of MDL-100907 [11C]-labeled at the 3'-methoxy group has been described: Condensation of 2-(4-fluorophenyl)ethyl bromide (I) with piperidine-4-carboxylic acid ethyl ester (II) by means of K2CO3 in DMF gives 1-[2-(4-fluorophenyl)ethyl]piperidine-4-carboxylic acid ethyl ester (III), which is treated with N,O-dimethylhydroxylamine and ethylmagnesium bromide in THF yielding the carbohydroxamic ester (IV). The condensation of (IV) with the silylated guaiacole (V) by means of n-BuLi in THF affords the 4-benzoylpiperidine (VI), which is reduced with NaBH4 in methanol giving the racemic carbinol (VII). Optical resolution of (VII) by esterification with (S)-2-methoxy-2-phenylacetic acid (VIII) by means of DCC and DMAP in chloroform followed by column chromatography yields the diastereomer (IX), which is simultaneously hydrolyzed and desilylated with K2CO3 in methanol affording the chiral carbinol (X). Finally, (X) is methylated with [11C]-methyl iodide and K2CO3 in methanol.
【1】
Mathis, C.A.; Huang, Y.Y.; Mahmood, K.; An efficient synthesis of the precursors of [11C]MDL 100907 labeled in two specific positions. J Label Compd Radiopharm 1999, 42, 10, 949.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17394 |
1-(2-bromoethyl)-4-fluorobenzene
|
|
C8H8BrF |
详情 |
详情
|
(II) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(III) |
17411 |
ethyl 1-(4-fluorophenethyl)-4-piperidinecarboxylate
|
|
C16H22FNO2 |
详情 |
详情
|
(IV) |
17412 |
1-(4-fluorophenethyl)-N-methoxy-N-methyl-4-piperidinecarboxamide
|
|
C16H23FN2O2 |
详情 |
详情
|
(V) |
40496 |
tert-butyl(2-methoxyphenoxy)diphenylsilane; tert-butyl(diphenyl)silyl 2-methoxyphenyl ether
|
|
C23H26O2Si |
详情 |
详情
|
(VI) |
40497 |
(3-[[tert-butyl(diphenyl)silyl]oxy]-2-methoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanone
|
|
C37H42FNO3Si |
详情 |
详情
|
(VII) |
40498 |
(3-[[tert-butyl(diphenyl)silyl]oxy]-2-methoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanol
|
|
C37H44FNO3Si |
详情 |
详情
|
(VIII) |
17401 |
(R)-(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methyl (2S)-2-methoxy-2-phenylethanoate
|
|
C31H36FNO5 |
详情 |
详情
|
(IX) |
40499 |
(R)-(3-[[tert-butyl(diphenyl)silyl]oxy]-2-methoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methyl (2S)-2-methoxy-2-phenylethanoate
|
|
C46H52FNO5Si |
详情 |
详情
|
(X) |
17413 |
3-[(R)-[1-(4-fluorophenethyl)-4-piperidinyl](hydroxy)methyl]-2-methoxyphenol
|
|
C21H26FNO3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(VI) The chlorination of 8-acetamido-2,3-dihydro-1,4-benzodioxin-5-carboxylic acid (I) with chlorine in acetic acid gives the 7-chloro derivative (II), which is treated with aqueous NaOH to yield 8-amino-2,3-dihydro-1,4-benzodioxin-5-carboxylic acid (III). The reaction of (III) with carbonyldiimidazole (CDI) affords the activated intermediate (IV), which is finally condensed with 1-(1-butylpiperidin-4-yl)methanol (V) by means of MeLi in THF.
The intermediate 1-(1-butylpiperidin-4-yl)methanol (V) has been obtained by condensation of piperidine-4-carboxylic acid ethyl ester (VI) with 1-bromobutane (VII) by means of K2CO3 in methanol, followed by reduction of the ester group with LiAlH4 in THF.
【1】
Bulteau, G.; Acher, J.; Thominet, M.; Collignon, C. (Ile de France); Substituted 2,3-alkylenedioxybenzamides. DE 2734270; FR 2360305; GB 1571278; GB 1571447; JP 53018570; US 4186135; US 4248885; US 4255580 .
|
【2】
Gaster, L.M.; Sanger, G.J.; SB-204070: 5-HT4 receptor antagonists and their potential therapeutic utility. Drugs Fut 1994, 19, 12, 1109.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41270 |
8-(acetamido)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid
|
|
C11H11NO5 |
详情 |
详情
|
(II) |
41271 |
8-(acetamido)-7-chloro-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid
|
|
C11H10ClNO5 |
详情 |
详情
|
(III) |
41272 |
8-amino-7-chloro-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid
|
|
C9H8ClNO4 |
详情 |
详情
|
(IV) |
41273 |
(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)(1H-imidazol-1-yl)methanone
|
|
C12H10ClN3O3 |
详情 |
详情
|
(V) |
41274 |
(1-butyl-4-piperidinyl)methanol
|
|
C10H21NO |
详情 |
详情
|
(VI) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(VII) |
28721 |
1-bromobutane
|
109-65-9 |
C4H9Br |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) Condensation of ethyl 4-piperidinecarboxylate (I) with benzoyl chloride in pyridine afforded the corresponding benzamide (II). After reduction of the ester group of (II) with NaBH4, the resulting alcohol (III) was converted to chloride (IV) by means of SOCl2. Elimination of the chlorine atom of (IV) with potassium tert-butoxide produced N-benzoyl-4-methylenepiperidine (V), which was hydrolyzed with KOH to yield 4-methylenepiperidine (VI). Finally, condensation of (VI) with the known epoxide (VII) in refluxing EtOH furnished the title compound.
【1】
Ogura, H.; et al.; Synthesis and antifungal activities of (2R,3R)-2-aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives as topical antifungal agents. Chem Pharm Bull 1999, 47, 10, 1417.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
31733 |
ethyl 1-benzoyl-4-piperidinecarboxylate
|
|
C15H19NO3 |
详情 |
详情
|
(III) |
31734 |
[4-(hydroxymethyl)-1-piperidinyl](phenyl)methanone
|
|
C13H17NO2 |
详情 |
详情
|
(IV) |
31735 |
[4-(chloromethyl)-1-piperidinyl](phenyl)methanone
|
|
C13H16ClNO |
详情 |
详情
|
(V) |
31736 |
(4-methylene-1-piperidinyl)(phenyl)methanone
|
|
C13H15NO |
详情 |
详情
|
(VI) |
31737 |
4-methylenepiperidine
|
|
C6H11N |
详情 |
详情
|
(VII) |
31738 |
1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole
|
|
C12H11F2N3O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) Ethyl isonipecotate (I) was protected as the N-trityl derivative (II) using triphenylmethyl chloride and triethylamine. Addition of Grignard reagent (IV) (prepared from 1-bromo-4-fluorobenzene (III) and magnesium in Et2O) to (II) produced the diaryl carbinol (V). Alcohol dehydration with simultaneous trityl group cleavage under acidic conditions yielded 4-[bis(4-fluorophenyl)methylene]piperidine (VI). 4-Chlorobutyrylpyrrolidine (IX), prepared by coupling of 4-chlorobutyryl chloride (VII) and pyrrolidine (VIII), was then condensed with piperidine (VI) to yield the target compound.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
33780 |
ethyl 1-trityl-4-piperidinecarboxylate
|
|
C27H29NO2 |
详情 |
详情
|
(III) |
29012 |
1-bromo-4-fluorobenzene
|
460-00-4 |
C6H4BrF |
详情 | 详情
|
(IV) |
13643 |
4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide |
352-13-6 |
C6H4BrFMg |
详情 | 详情
|
(V) |
33781 |
bis(4-fluorophenyl)(1-trityl-4-piperidinyl)methanol
|
|
C37H33F2NO |
详情 |
详情
|
(VI) |
24706 |
4-[bis(4-fluorophenyl)methylene]piperidine
|
|
C18H17F2N |
详情 |
详情
|
(VII) |
11265 |
4-Chlorobutanoyl chloride; 4-Chlorobutyric acid chloride
|
4635-59-0 |
C4H6Cl2O |
详情 | 详情
|
(VIII) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(IX) |
33782 |
4-chloro-1-(1-pyrrolidinyl)-1-butanone
|
|
C8H14ClNO |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) Reduction of ethyl 4-piperidinecarboxylate (I) with LiAlH4 in THF provided 4-piperidinemethanol (II), which was coupled with 3-ethoxybenzoyl chloride (III) in the presence of Et3N, yielding amide (IV). Subsequent treatment of (IV) with p-toluenesulfonyl chloride in pyridine afforded the corresponding tosylate (V. This was finally condensed with 5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline (VI) to furnish the title compound.
【1】
George, P.; Sevrin, M.; Maloizel, C.; Tixidre, A.; Froissant, J. (Sanofi-Synthelabo ); Derivs. of 2-[(4-piperidinyl)methyl]-1,2,3, 4-tetrahydroisoquinoline, their use in therapy. AU 8929617; EP 0351255; JP 1990025481; US 4925850 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
32954 |
4-piperidinylmethanol
|
|
C6H13NO |
详情 |
详情
|
(III) |
32955 |
3-ethoxybenzoyl chloride
|
61956-65-8 |
C9H9ClO2 |
详情 | 详情
|
(IV) |
32956 |
(3-ethoxyphenyl)[4-(hydroxymethyl)-1-piperidinyl]methanone
|
|
C15H21NO3 |
详情 |
详情
|
(V) |
32957 |
[1-(3-ethoxybenzoyl)-4-piperidinyl]methyl 4-methylbenzenesulfonate
|
|
C22H27NO5S |
详情 |
详情
|
(VI) |
32958 |
5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 5-methoxy-1,2,3,4-tetrahydro-8-isoquinolinyl methyl ether
|
|
C11H15NO2 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(IV) Protection of 3-methyl-3-sulfanylbutanoic acid (I) by treatment with 2,4,6-trimethoxybenzyl alcohol (II) and trifluoroacetic acid produced the trimethoxybenzyl thioether (III). Subsequent coupling of (III) with ethyl isonipecotate (IV) using EDC and DMAP gave amide (V). The ethyl ester group of (V) was then hydrolyzed to carboxylic acid (VI) by means of ethanolic NaOH. This was then condensed with 4-[2-(dimethylamino)ethoxy]-2-methyl-5-isopropylphenol (VIII), prepared by basic hydrolysis of moxisylyte (VII), and the resulting ester (IX) was deprotected with trifluoroacetic acid to give thiol (X). Finally, S-nitrosation of (X) with tert-butyl nitrite, followed by treatment with succinic acid furnished the title compound.
【1】
Earl, R.A.; et al.; Nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of erectile dysfunction. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 239.
|
【2】
Gaston, R.D.; Saenz de Tejada, I.; Schroeder, J.D.; Shelekhin, T.E.; Garvey, D.S.; Wang, T. (NitroMed Inc.); Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compsns. and methods of use. WO 0012075 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32947 |
3-methyl-3-sulfanylbutyric acid
|
|
C5H10O2S |
详情 |
详情
|
(II) |
38877 |
(2,4,6-trimethoxyphenyl)methanol
|
|
C10H14O4 |
详情 |
详情
|
(III) |
38878 |
3-methyl-3-[(2,4,6-trimethoxybenzyl)sulfanyl]butyric acid
|
|
C15H22O5S |
详情 |
详情
|
(IV) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(V) |
38879 |
ethyl 1-[3-methyl-3-[(2,4,6-trimethoxybenzyl)sulfanyl]butanoyl]-4-piperidinecarboxylate
|
|
C23H35NO6S |
详情 |
详情
|
(VI) |
38880 |
1-[3-methyl-3-[(2,4,6-trimethoxybenzyl)sulfanyl]butanoyl]-4-piperidinecarboxylic acid
|
|
C21H31NO6S |
详情 |
详情
|
(VII) |
38875 |
4-[2-(dimethylamino)ethoxy]-5-isopropyl-2-methylphenyl acetate
|
|
C16H25NO3 |
详情 |
详情
|
(VIII) |
38876 |
4-[2-(dimethylamino)ethoxy]-5-isopropyl-2-methylphenol
|
|
C14H23NO2 |
详情 |
详情
|
(IX) |
38881 |
4-[2-(dimethylamino)ethoxy]-5-isopropyl-2-methylphenyl 1-[3-methyl-3-[(2,4,6-trimethoxybenzyl)sulfanyl]butanoyl]-4-piperidinecarboxylate
|
|
C35H52N2O7S |
详情 |
详情
|
(X) |
38882 |
4-[2-(dimethylamino)ethoxy]-5-isopropyl-2-methylphenyl 1-(3-methyl-3-sulfanylbutanoyl)-4-piperidinecarboxylate
|
|
C25H40N2O4S |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IX) An alternative preparation for the title compound consisted in the reductive alkylation of ethyl isonipecotate (IX) with acetone to afford the N-isopropyl isonipecotate (X). After basic hydrolysis of the ethyl ester group of (X), the resulting carboxylic acid (XI) was activated as the mixed anhydride (XII) with isobutyl chloroformate. Anhydride (XII) was finally coupled to aniline (IV) to generate the required amide.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(X) |
44139 |
ethyl 1-isopropyl-4-piperidinecarboxylate
|
|
C11H21NO2 |
详情 |
详情
|
(XI) |
44140 |
1-isopropyl-4-piperidinecarboxylic acid
|
|
C9H17NO2 |
详情 |
详情
|
(XII) |
44141 |
|
|
C14H25NO4 |
详情 |
详情
|
(XIII) |
44135 |
2-amino-5-chloro-N-(5-chloro-2-pyridinyl)benzamide
|
|
C12H9Cl2N3O |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) Ethyl isonipecotate (I) was protected as the N-Boc derivative (II) employing di-tert-butyl dicarbonate. Sulfenylation of the lithium enolate of ester (II) with the disulfide (IV), generated from the oxidation of 4-fluorothiophenol (III), furnished the phenylsulfanyl derivative (V). Thioether (V) was then oxidized to the corresponding sulfone (VI) by means of meta-chloroperbenzoic acid. After acidic Boc group cleavage in (VI), the resultant piperidine (VII) was alkylated with propargyl bromide (VIII) to produce the N-propargyl piperidine (IX).
【1】
Becker, D.P.; Hockerman, S.L.; Barta, T.E.; et al.; Design and synthesis of beta-sulfone and alpha-sulfone hydroxamates as potent and orally active MMP inhibitors. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 259.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
49847 |
1-(tert-butyl) 4-ethyl-1,4-piperidinedicarboxylate; N-Boc-4-Carbethoxypiperidine
|
142851-03-4 |
C13H23NO4 |
详情 | 详情
|
(III) |
22971 |
4-fluorobenzenethiol; 4-fluorophenylhydrosulfide; 4-Fluorothiophenol
|
371-42-6 |
C6H5FS |
详情 | 详情
|
(IV) |
52287 |
bis(4-fluorophenyl) disulfide; 1-fluoro-4-[(4-fluorophenyl)disulfanyl]benzene
|
|
C12H8F2S2 |
详情 |
详情
|
(V) |
52288 |
1-(1,1-dimethylethyl) 4-ethyl 4-[(4-fluorophenyl)sulfanyl]-1,4-piperidinedicarboxylate
|
|
C19H26FNO4S |
详情 |
详情
|
(VI) |
52289 |
1-(1,1-dimethylethyl) 4-ethyl 4-[(4-fluorophenyl)sulfonyl]-1,4-piperidinedicarboxylate
|
|
C19H26FNO6S |
详情 |
详情
|
(VII) |
52290 |
ethyl 4-[(4-fluorophenyl)sulfonyl]-4-piperidinecarboxylate
|
|
C14H18FNO4S |
详情 |
详情
|
(VIII) |
11176 |
3-Bromopropyne; 3-Bromo-1-propyne
|
106-96-7 |
C3H3Br |
详情 | 详情
|
(IX) |
56377 |
ethyl 4-[(4-fluorophenyl)sulfonyl]-1-(2-propynyl)-4-piperidinecarboxylate
|
|
C17H20FNO4S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(I) Ethyl nipecotate (I) was protected as the tert-butyl carbamate (II) upon treatment with Boc2O in THF. The lithium enolate of ester (II) was then sulfenylated with the disulfide (IV), prepared by oxidation of 4-fluorothiophenol (III), yielding thioether (V). This was further oxidized to the corresponding sulfone (VI) using meta-chloroperbenzoic acid. Acid cleavage of the Boc protecting group of (VI) gave piperidine (VII), which was converted to the N-cyclopropyl amine (IX) by reductive alkylation with [(1-ethoxycyclopropyl)oxy]trimethylsilane (VIII) in the presence of NaBH3CN. Displacement of the aryl fluoride of (IX) with 4-(trifluoromethoxy)phenol (X) under basic conditions afforded the diaryl ether (XI). After saponification of the ester group of (XI), the resultant carboxylic acid (XII) was coupled to O-(tetrahydropyranyl)hydroxylamine by means of EDC to produce the protected hydroxamate (XIII). Finally, removal of the tetrahydropyranyl protecting group of (XIII) with HCl in dioxan afforded the title compound.
【1】
Villamil, C.I.; et al.; Design and synthesis of 4,4-disubstituted piperidine alpha-sulphone hydroxamates as potent and selective MMP inhibitors: The discovery of SC-77964. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 258.
|
【2】
Aromatic sulfone hydroxamic acid metalloprotease inhibitor. WO 0050396 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
49847 |
1-(tert-butyl) 4-ethyl-1,4-piperidinedicarboxylate; N-Boc-4-Carbethoxypiperidine
|
142851-03-4 |
C13H23NO4 |
详情 | 详情
|
(III) |
22971 |
4-fluorobenzenethiol; 4-fluorophenylhydrosulfide; 4-Fluorothiophenol
|
371-42-6 |
C6H5FS |
详情 | 详情
|
(IV) |
52287 |
bis(4-fluorophenyl) disulfide; 1-fluoro-4-[(4-fluorophenyl)disulfanyl]benzene
|
|
C12H8F2S2 |
详情 |
详情
|
(V) |
52288 |
1-(1,1-dimethylethyl) 4-ethyl 4-[(4-fluorophenyl)sulfanyl]-1,4-piperidinedicarboxylate
|
|
C19H26FNO4S |
详情 |
详情
|
(VI) |
52289 |
1-(1,1-dimethylethyl) 4-ethyl 4-[(4-fluorophenyl)sulfonyl]-1,4-piperidinedicarboxylate
|
|
C19H26FNO6S |
详情 |
详情
|
(VII) |
52290 |
ethyl 4-[(4-fluorophenyl)sulfonyl]-4-piperidinecarboxylate
|
|
C14H18FNO4S |
详情 |
详情
|
(VIII) |
52291 |
Cyclopropanone ethyl trimethylsilyl acetal; (1-Ethoxycyclopropoxy)trimethylsilane
|
|
C8H18O2Si |
详情 |
详情
|
(IX) |
52292 |
ethyl 1-cyclopropyl-4-[(4-fluorophenyl)sulfonyl]-4-piperidinecarboxylate
|
|
C17H22FNO4S |
详情 |
详情
|
(X) |
18780 |
4-(trifluoromethoxy)phenol
|
828-27-3 |
C7H5F3O2 |
详情 | 详情
|
(XI) |
52293 |
ethyl 1-cyclopropyl-4-{[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]sulfonyl}-4-piperidinecarboxylate
|
|
C24H26F3NO6S |
详情 |
详情
|
(XII) |
52294 |
1-cyclopropyl-4-{[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]sulfonyl}-4-piperidinecarboxylic acid
|
|
C22H22F3NO6S |
详情 |
详情
|
(XIII) |
52295 |
1-cyclopropyl-N-(tetrahydro-2H-pyran-2-yloxy)-4-{[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]sulfonyl}-4-piperidinecarboxamide
|
|
C27H31F3N2O7S |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(I) Ethyl isonipecotate (I) was protected as the N-Boc derivative (II) and then reduced to alcohol (III) using LiAlH4. Treatment of alcohol (III) with p-toluenesulfonyl chloride in the presence of DBU afforded the intermediate tosylate (IV).
【1】
Hennequin, L.F.A.; Stokes, E.S.E.; Thomas, A.P. (AstraZeneca AB; AstraZeneca plc); Quinazoline derivs. as VEGF inhibitors. WO 0132651 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
49847 |
1-(tert-butyl) 4-ethyl-1,4-piperidinedicarboxylate; N-Boc-4-Carbethoxypiperidine
|
142851-03-4 |
C13H23NO4 |
详情 | 详情
|
(III) |
40399 |
tert-butyl 4-(hydroxymethyl)-1-piperidinecarboxylate
|
|
C11H21NO3 |
详情 |
详情
|
(IV) |
49848 |
tert-butyl 4-([[(4-methylphenyl)sulfonyl]oxy]methyl)-1-piperidinecarboxylate
|
|
C18H27NO5S |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(IX) The intermediate silyl sulfide (II) was prepared by palladium-catalyzed displacement of 5-bromo-1-methylindole (I) with potassium (triisopropylsilyl)sulfide. Alternatively, 5-iodoindole (III) was N-methylated with iodomethane and NaH, yielding 5-iodo-1-methylindole (IV), which was then reacted with potassium (triisopropylsilyl)sulfide to give (II). Condensation of silyl sulfide (II) with the aryl triflate (V) in the presence of CsF as the desilylating reagent furnished the diaryl sulfide (VI). Knoevenagel condensation of aldehyde (VI) with malonic acid (VII) gave rise to the cinnamic acid derivative (VIII). This was then coupled with ethyl isonipecotate (IX), producing amide (X). The ethyl ester of (X) was finally hydrolyzed with NaOH to yield the title sodium carboxylate salt.
【1】
Reilly, E.B.; Liu, G.; Winn, M.; et al.; Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 4. Structure-activity relationships of substituents on the benzene ring of the cinnamide. J Med Chem 2001, 44, 25, 4393. |
【2】
Jae, H.-S.; Pei, Z.; Staeger, M.A.; Gunawardana, I.W.; Winn, M.; Freeman, J.C.; Liu, G.; Link, J.; Boyd, S.A.; Zhu, G.-D.; Von Geldern, T.W.; Xin, Z.; Lynch, J.K.; Wang, S. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory and immune-suppressive cpds.. WO 0059880 . |
【3】
Lynch, J.K.; Link, J.; Zhu, G.-D.; Boyd, S.A.; Winn, M.; Pei, Z.; Gunawardana, I.W.; Liu, G.; Xin, Z.; Jae, H.-S.; Freeman, J.C.; Von Geldern, T.; Staeger, M.A. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory and immune-suppressive cpds.. US 6110922; WO 0039081 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29521 |
5-bromo-1-methyl-1H-indole
|
|
C9H8BrN |
详情 |
详情
|
(II) |
53020 |
1-methyl-5-[(triisopropylsilyl)sulfanyl]-1H-indole; 1-methyl-1H-indol-5-yl triisopropylsilyl sulfide
|
n/a |
C18H29NSSi |
详情 | 详情
|
(III) |
40983 |
5-iodo-1H-indole
|
|
C8H6IN |
详情 |
详情
|
(IV) |
53021 |
5-iodo-1-methyl-1H-indole
|
n/a |
C9H8IN |
详情 | 详情
|
(V) |
52029 |
2,3-dichloro-4-formylphenyl trifluoromethanesulfonate
|
|
C8H3Cl2F3O4S |
详情 |
详情
|
(VI) |
53022 |
2,3-dichloro-4-[(1-methyl-1H-indol-5-yl)sulfanyl]benzaldehyde
|
n/a |
C16H11Cl2NOS |
详情 | 详情
|
(VII) |
12963 |
Malonic acid
|
141-82-2 |
C3H4O4 |
详情 | 详情
|
(VIII) |
53023 |
(E)-3-{2,3-dichloro-4-[(1-methyl-1H-indol-5-yl)sulfanyl]phenyl}-2-propenoic acid
|
n/a |
C18H13Cl2NO2S |
详情 | 详情
|
(IX) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(X) |
53024 |
ethyl 1-((E)-3-{2,3-dichloro-4-[(1-methyl-1H-indol-5-yl)sulfanyl]phenyl}-2-propenoyl)-4-piperidinecarboxylate
|
n/a |
C26H26Cl2N2O3S |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(II) The condensation between 2-fluorobenzonitrile (I) and ethyl isonipecotate (II) produced the piperidino benzonitrile (III). Reduction of nitrile and ester functions of (III) to afford the intermediate amino alcohol (IV) was accomplished using either LiAlH4 or, in a more practical, scalable procedure, using NaBH4/ZnCl2.
【1】
Fujino, K.; et al.; Development of a practical synthetic route of a PDE V inhibitor KF31327. Org Process Res Dev 2001, 5, 4, 426.
|
【2】
Fujino, K.; et al.; Process development of a PDE V inhibitor KF31327. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst ORGN 612.
|
【3】
Onoda, Y.; Nomoto, Y.; Ohno, T.; Yamada, K.; Ichimura, M. (Kyowa Hakko Kogyo Co., Ltd.); Imidazoquinazoline derivs.. EP 0863144; WO 9808848 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41199 |
2-fluorobenzonitrile
|
394-47-8 |
C7H4FN |
详情 | 详情
|
(II) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(III) |
54824 |
ethyl 1-(2-cyanophenyl)-4-piperidinecarboxylate
|
|
C15H18N2O2 |
详情 |
详情
|
(IV) |
54825 |
{1-[2-(aminomethyl)phenyl]-4-piperidinyl}methanol
|
|
C13H20N2O |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(VI) 4-Hydroxydiphenylmethane (I) is condensed with tert-butyl bromoacetate (II) in the presence of NaH and Bu-4NI to form the aryloxyacetate adduct (III). Ester group reduction in (III) employing LiAlH4 provides alcohol (IV), which is further treated with p-toluenesulfonyl chloride in pyridine, yielding tosylate (V) (1,2). Finally, condensation of tosylate (V) with ethyl isonipecotate (VI) furnishes the title compound (1-3).
【1】
Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase. Bioorg Med Chem Lett 2002, 12, 23, 3383.
|
【2】
Chandrakumar, N.S.; Chen, B.B.; Clare, M.; Desai, B.N.; Djuric, S.W.; Docter, S.H.; Gasiecki, A.F.; Haack, R.A.; Liang, C.-D.; Miyashiro, J.M.; Penning, T.D.; Russell, M.A.; Yu, S.S. (Pfizer Inc.); LTA4 hydrolase inhibitor pharmaceutical compsns. and methods of use. JP 1998512542; WO 9610999 . |
【3】
Chandrakumar, N.S.; Chen, B.B.; Clare, M.; Desai, B.N.; Djuric, S.W.; Docter, S.H.; Gasiecki, A.; Haack, R.A.; Liang, C.-D.; Miyashiro, J.M.; Penning, T.D.; Russell, M.A.; Yu, S.S. (Pfizer Inc.); LTA4 hydrolase inhibitors. EP 0804427; EP 1221441; JP 1998512848; WO 9611192 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50817 |
4-Hydroxydiphenylmethane; 4-Benzylphenol; alpha-Phenyl-p-cresol; p-Benzylphenol
|
101-53-1 |
C13H12O |
详情 | 详情
|
(II) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(III) |
64434 |
tert-butyl 2-(4-benzylphenoxy)acetate
|
|
C19H22O3 |
详情 |
详情
|
(IV) |
64435 |
2-(4-benzylphenoxy)-1-ethanol
|
|
C15H16O2 |
详情 |
详情
|
(V) |
64436 |
2-(4-benzylphenoxy)ethyl 4-methylbenzenesulfonate
|
|
C22H22O4S |
详情 |
详情
|
(VI) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(I) Alkylation of ethyl isonipecotate (I) with 1-bromo-2-chloroethane (II) in the presence of K2CO3 in acetone yields ethyl 1-(2-chloro-ethyl)piperidine-4-carboxylate (III), which by treatment with LDA in THF cyclizes to the quinuclidine derivative (IV) . Alternatively, quinuclidine (IV) can be prepared by alkylation of Boc-protected ethyl nipecotate (V) with 1-bromo-2-chloroethane (II) using LiHMDS in toluene to yield the 4-(2-chloroethyl)piperidine derivative (VI), which is then N-deprotected with HCl in water/dioxane, followed by cyclization of the resulting chloro amine (VII) by means of K2CO3 in refluxing toluene . Addition of phenyl lithium (VIII) to ester (IV) in THF affords 1-azabicyclo[2.2.2]oct-4-yl(diphenyl)methanol (IX), which finally undergoes quaternization with benzyl 2-bromoethyl ether (X) in acetonitrile/chloroform .
【1】
Lainé, D.I., McCleland, B., Thomas, S. et al. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists. J Med Chem 2009, 52(8): 2493-505. |
【2】
Lainé, D.I., Palovich, M.R., McCleland, B.W., Neipp, C.E., Thomas, S.M.(GlaxoSmithKline plc). Muscarinic acetylcholine receptor antagonists. CA 2564742, CN 102040602, EP 1740177, JP 2007534769, KR 2011010841, US 200785155, US 7498440, US 8183257, US 2012157491, US 8309572, US 2013030015, WO 2005104745. |
【3】
Carangio, A., Cheung, I., D’Souza, E.C.F., Leahy, J.H., Strachan, J.B. (GlaxoSmithKline plc). Methods of preparation of muscarinic acetylcholine receptor antagonists. WO 2011029896. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
24271 |
1-bromo-2-chloroethane
|
107-04-0 |
C2H4BrCl |
详情 | 详情
|
(III) |
67994 |
ethyl 1-(2-chloroethyl)piperidine-4-carboxylate |
|
C10H18ClNO2 |
详情 | 详情
|
(IV) |
67995 |
ethyl quinuclidine-4-carboxylate |
|
C10H17NO2 |
详情 | 详情
|
(V) |
49847 |
1-(tert-butyl) 4-ethyl-1,4-piperidinedicarboxylate; N-Boc-4-Carbethoxypiperidine
|
142851-03-4 |
C13H23NO4 |
详情 | 详情
|
(VI) |
67996 |
1-tert-butyl 4-ethyl 4-(2-chloroethyl)piperidine-1,4-dicarboxylate |
|
C15H26ClNO4 |
详情 | 详情
|
(VII) |
67997 |
ethyl 4-(2-chloroethyl)piperidine-4-carboxylate hydrochloride |
|
C10H18ClNO2.HCl |
详情 | 详情
|
(VIII) |
24014 |
Phenyllithium
|
591-51-5 |
C6H5Li |
详情 | 详情
|
(IX) |
67998 |
diphenyl(quinuclidin-4-yl)methanol;1-azabicyclo[2.2.2]oct-4-yl(diphenyl)methanol |
|
C20H23NO |
详情 | 详情
|
(X) |
35528 |
1-[(2-bromoethoxy)methyl]benzene; benzyl 2-bromoethyl ether
|
1462-37-9 |
C9H11BrO |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(IX) Bromination of 1-(4-chloro-2-thienyl)ethanone (I) with Br2 in Et2O gives 2-bromo-1-(4-chloro-2-thienyl)ethanone (II), which by cyclocondensation with thiourea (III) in EtOH at 80 °C provides 2-amino-4-(4-chloro-2-thienyl)thiazole (IV). Treatment of thiazole (IV) with NBS in DMF and subsequent condensation with 1-cyclohexylpiperazine (V) by means of Et3N at 70 °C affords the 5-piperazinyl-thiazole derivative (VI). Coupling of the 2-aminothiazole (VI) with 5,6-dichloronicotinic acid (VII) in the presence of POCl3 in pyridine yields amide (VIII), which is then condensed with ethyl isonipecotate (IX) in THF at 50 °C to obtain the ethyl 1-(pyridyl)piperidine-4-carboxylate derivative (X). Finally, ethyl ester (X) is hydrolyzed by means of NaOH in MeOH .
【1】
Watanuki, S., Nagata, H., Wakayama, R. et al. 2-Acylaminothiazole derivative or salt thereof. EP 1466912, EP 2314586, JP 2009111001, US 2005153977, US 7638536, US 2010222329, US 2010222361, WO 2003062233. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68277 |
1-(4-chloro-2-thienyl)ethanone;4-Chloro-2-acetylthiophene |
34730-20-6 |
C6H5ClOS |
详情 | 详情
|
(II) |
68278 |
2-bromo-1-(4-chloro-2-thienyl)ethanone |
|
C6H4BrClOS |
详情 | 详情
|
(III) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(IV) |
68279 |
2-amino-4-(4-chloro-2-thienyl)thiazole |
|
C7H5ClN2S2 |
详情 | 详情
|
(V) |
23174 |
1-cyclohexylpiperazine
|
17766-28-8 |
C10H20N2 |
详情 | 详情
|
(VI) |
68280 |
4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine |
|
C17H23ClN4S2 |
详情 | 详情
|
(VII) |
68282 |
5,6-dichloronicotinic acid |
41667-95-2 |
C6H3Cl2NO2 |
详情 | 详情
|
(VIII) |
68281 |
5,6-dichloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)nicotinamide |
|
C23H24Cl3N5OS2 |
详情 | 详情
|
(IX) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(X) |
68283 |
ethyl 1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylate |
|
C31H38Cl2N6O3S2 |
详情 | 详情
|